Health Care: Drugs

Rockwell Medical Inc (RMTI: NASDAQ)

$8.72 -0.66 | -7.04%
10/31/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 9.38
52 Week High 15.85
52 Week Low 8.66
Avg. Daily Vol. (Mil) 0.42
Beta (3 year) 1.71
Share Related Items
Mkt Cap (Mil) 383.60
Shares Out (Mil) 40.90
Float (Mil) 38.46
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.20
Current Ratio 1.40
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 7.23
Price/Book 0.00
Price/Cash Flow -12.40
Per Share Data
Earnings -0.78
Sales 1.30
Book Value 0.00
Cash Flow -0.76
Business Summary
Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis.
General Information
30142 Wixom Road
Wixom, MI 48393
www.rockwellmed.com
Industry : Drugs
Sector: Health Care
Employees: 286
CEO: Robert L. Chioini
Short Interest
Current Month (Mil) 7.96
Previous Month (Mil) 7.49
Short Interest Ratio (Days) 15.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -125.60
Return on Investments -307.70
Profitability
Gross Margin 16.70
EBIT Margin -54.80
Profit Margin -61.30

Portfolios with RMTI

Latest RMTI Headlines from TheStreet

More Financial News for RMTI

Press Releases for RMTI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter